close
MENU
Hot Topic Summer features
Hot Topic Summer features
Tech & Innovation
10 mins to read

Pacific Edge knocked down... can it get up again?

The cancer diagnostic company mulls counter-punches after game-changing payment blow.

It was surprising last week to learn Harbour Asset Management had increased its shareholding in beleaguered cancer diagnostic company Pacific Edge to 14.5% from 13.48%.

To use a boxing analogy, the dual-listed Pacific Edge is still reeling from a heavy blow, that its Cxbladder tests will no longer

Want to read more? It's easy.

Choose your best value subscription option

Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Fiona Rotherham Mon, 19 Jun 2023
Contact the Writer: fiona@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Company profile
Powered by: nzx logo
Change:
Price
Previous Close
Turnover
Movement
Volume
Avg Daily Volume
Daily High
Daily Low
52 Week High
52 Week Low
Pacific Edge knocked down... can it get up again?
Tech & Innovation,
99562
true